Capturing SARS-cov in low abundant patient samples: a comparative analysis (Illumina respv NS).
Ontology highlight
ABSTRACT: In this study, we tested the efficacy of five commercial probes panels at detecting SARS-CoV-2 genome including panels from Illumina, Twist Bioscience and Arbor Bioscience. To do so, we used 19 patient nasal swab samples broken down into 5 series of 4 samples of equivalent SARS-CoV-2 viral load (cycle threshold (CT): low CT means a high viral load – CT26, CT29, CT32, CT35 and CT36+).
INSTRUMENT(S): NextSeq 500
ORGANISM(S): Homo sapiens
SUBMITTER: thomas cokelaer
PROVIDER: E-MTAB-11233 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA